We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+5%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.3B
AUM Growth
+$535M
(+1.3%)
Cap. Flow
-$468M
Cap. Flow
% of AUM
-1.16%
Top 10 Holdings %
Top 10 Hldgs %
15.78%
Holding
2,279
New
170
Increased
711
Reduced
1,071
Closed
189
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$178M |
| 2 |
LyondellBasell Industries
LYB
|
+$133M |
| 3 |
AT&T
T
|
+$124M |
| 4 |
Stanley Black & Decker
SWK
|
+$101M |
| 5 |
Pfizer
PFE
|
+$93.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$229M |
| 2 |
Gilead Sciences
GILD
|
+$164M |
| 3 |
Broadcom
AVGO
|
+$149M |
| 4 |
KeyCorp
KEY
|
+$145M |
| 5 |
Darden Restaurants
DRI
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.22% |
| 2 | Technology | 14.47% |
| 3 | Financials | 10.84% |
| 4 | Industrials | 9.01% |
| 5 | Consumer Discretionary | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
First Watch Restaurant Group
FWRG
$700M
| $30.1M | 0.07% |
1,780,400
+200,100
| +13% | +$3.31M |
|
302
Credicorp
BAP
$29.9B
| $29.8M | 0.07% |
201,543
-823
| -0.4% | -$113K |
|
303
Microchip Technology
MCHP
$38.8B
| $29.7M | 0.07% |
331,677
-78,429
| -19% | -$6.19M |
|
304
Albemarle
ALB
$13.6B
| $29.3M | 0.07% |
131,406
-60,277
| -31% | -$12.3M |
|
305
Alliant Energy
LNT
$17.4B
| $29.2M | 0.07% |
555,665
-7,019
| -1% | -$376K |
|
306
Comcast
CMCSA
$88.3B
| $28.7M | 0.07% |
690,569
-6,713
| -1% | -$267K |
|
307
Lowe's Companies
LOW
$111B
| $28.7M | 0.07% |
127,069
+106,084
| +506% | +$22.1M |
|
308
ConocoPhillips
COP
$164B
| $28.6M | 0.07% |
276,066
-26,209
| -9% | -$2.69M |
|
309
CRISPR Therapeutics
CRSP
$5.12B
| $28.6M | 0.07% |
508,758
| – | – |
|
310
SoundThinking
SSTI
$73.8M
| $28.3M | 0.07% |
1,295,000
+35,000
| +3% | +$916K |
|
311
Five Below
FIVE
$13.7B
| $27.8M | 0.07% |
141,564
+54,716
| +63% | +$10.7M |
|
312
Allison Transmission
ALSN
$10.5B
| $27.8M | 0.07% |
491,990
+27,132
| +6% | +$1.33M |
|
313
Xponential Fitness
XPOF
$174M
| $27.4M | 0.07% |
1,589,772
-37,965
| -2% | -$1.07M |
|
314
Netflix
NFLX
$334B
| $27.4M | 0.07% |
622,260
-189,770
| -23% | -$6.99M |
|
|
MASI
315
DELISTED
Masimo
MASI
| $27.4M | 0.07% |
166,235
+112,708
| +211% | +$19.6M |
|
316
Kenvue
KVUE
$34.4B
| $27.2M | 0.07% |
+1,027,835
| New | +$26.8M |
|
317
Assurant
AIZ
$13.9B
| $27.1M | 0.07% |
215,304
-3,698
| -2% | -$460K |
|
318
Telefônica Brasil
VIV
$19B
| $26.7M | 0.07% |
2,922,376
-18,348
| -0.6% | -$154K |
|
319
Zimmer Biomet
ZBH
$17.8B
| $26.5M | 0.07% |
181,835
-882
| -0.5% | -$120K |
|
320
NVR
NVR
$16.4B
| $26M | 0.06% |
4,101
-154
| -4% | -$896K |
|
321
Northern Trust
NTRS
$34.6B
| $26M | 0.06% |
350,914
-9,668
| -3% | -$742K |
|
322
Coca-Cola Europacific Partners
CCEP
$46.1B
| $25.7M | 0.06% |
399,617
-87,940
| -18% | -$5.58M |
|
323
Exelon
EXC
$44.5B
| $25.3M | 0.06% |
621,426
-7,837
| -1% | -$324K |
|
324
Lantheus
LNTH
$6.55B
| $25.2M | 0.06% |
300,262
+133,172
| +80% | +$12M |
|
325
Illumina
ILMN
$31.4B
| $25.1M | 0.06% |
137,856
-5,813
| -4% | -$1.18M |
|
Similar funds
Federated Hermes's Q2 2023 Portfolio in Review
As of Q2 2023, Federated Hermes held 2,279 positions worth $40.3B, up 1.3% from $39.7B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2023 filing shows 170 new, 711 increased, 1,071 reduced and 189 closed positions. Its largest new stake was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M. The largest sale was Clorox, an estimated $229M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 20% a quarter earlier, followed by Technology and Financials.
- Federated Hermes's largest Q2 2023 buy was HashiCorp, Inc. Class A Common Stock: 1,317,400 shares worth $34.5M.
- Federated Hermes added most to Amgen in Q2 2023, an estimated $178M increase.
- Federated Hermes's biggest Q2 2023 reduction was Clorox, cutting an estimated $229M.
- Federated Hermes fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $55.4M.
- Federated Hermes's ten largest holdings make up 16% of its $40.3B portfolio in Q2 2023.
- Federated Hermes opened 170 new positions and closed 189 in Q2 2023.
- Federated Hermes's portfolio value rose 1.3% quarter-over-quarter to $40.3B.
Based on Federated Hermes's 13F filing for Q2 2023, filed 14 Aug 2023.